Evidence map›Paper›PMID 26294993›Full record

ArticleCase reports in oncological medicine2015

Primary Intracranial Melanoma with Early Leptomeningeal Spread: A Case Report and Treatment Options Available.

Rajesh Balakrishnan, Rokeya Porag, Dewan Shamsul Asif, A M Rejaus Satter, Md Taufiq, Samson S K Gaddam

Open access · goldAbstract read
In one paragraph

Article in Case reports in oncological medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Clinics in diagnostic imaging (222).Singapore medical journal · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Primary Brain Melanoma in a Pediatric Patient: A Case Report.The American journal of case reports · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rajesh BalakrishnanDepartment of Radiotherapy and Oncology, Square HospitalsLimited, Dhaka 1205, Bangladesh.
Rokeya PoragDepartment of Neurosurgery, Square HospitalsLimited, Dhaka 1205, Bangladesh.
Dewan Shamsul AsifDepartment of Neurosurgery, Square HospitalsLimited, Dhaka 1205, Bangladesh.
A M Rejaus SatterDepartment of Neurosurgery, Square HospitalsLimited, Dhaka 1205, Bangladesh.
Md TaufiqDepartment of Pathology, Square HospitalsLimited, Dhaka 1205, Bangladesh.
Samson S K GaddamDepartment of Neurosurgery, Square HospitalsLimited, Dhaka 1205, Bangladesh.
Square Hospitals · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary CNS melanomas are rare and they constitute about 1% of all cases of melanomas and 0.07% of all brain tumors. These tumors are aggressive in nature and may metastasise to other organs. Till date less than 25 cases have been reported in the literature. The primary treatment for local intraparenchymal tumours is complete resection and/or radiotherapy and it is associated with good survival. However once there is disease spread to leptomeninges the overall median survival is around 10 weeks. In this case report we describe a primary intracranial melanoma without any dural attachment in 16-year-old boy who had radical excision of the tumor followed by radiotherapy who eventually had rapidly developed leptomeningeal disease and review the literature with a focus on the clinic pathological, radiological, and treatment options.

Identifiers

PMID26294993
PMCPMC4532938
OpenAlexW1568690237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.